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Abstract The only surface membrane glycoprotein of Borna
disease virus (BDV) is synthesized as a polypeptide with a mo-
lecular mass of 57 kDa and N-glycosylated to a precursor gly-
coprotein (GP) of about 94 kDa. It is processed by the cellular
protease furin into the C-terminal membrane-anchored subunit
GP-C, also known as gp43, and a presumptive N-terminal sub-
unit GP-N, that is highly glycosylated and has a molecular mass
of about 51 kDa. However, up to now the latter remained un-
detected in BDV-infected material. We describe a novel ap-
proach to identify glycan masked linear antigenic epitopes. In
the present study, GP-N was identi¢ed in BDV-infected cells by
a combination of lectin precipitation, enzymatic deglycosylation
on blot and immunochemistry using an N-terminal speci¢c anti-
serum. The GP-N has an apparent molecular mass of 45^50
kDa in its glycosylated form and 27 kDa in its deglycosylated
form. N-glycan analysis revealed that the precursor GP contains
only mannose-rich N-glycans, whereas GP-N and GP-C contain
mannose-rich and complex-type N-glycans.
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1. Introduction
Borna disease virus (BDV) is the ethological agent of Borna
disease which is observed in a wide range of vertebrates, in
particular horses and sheep. Borna disease is a progressive
disease of the central nervous system caused by a T-cell-medi-
ated immunoreaction. It is also suspected to play a role in
human psychiatric disorders. The ¢ne structure and morpho-
genesis of BDV analyzed by electron microscopy revealed
spherical enveloped virus particles, approximately 90^130
nm in diameter. The virions are assembled at the cell surface
from where only small numbers of virions are released by
budding [1]. The BDV nucleocapsid contains a non-seg-
mented, single-stranded RNA of negative sense polarity,
which is replicated and transcribed in the nucleus of BDV-
infected cells. Because of these unusual properties, the few
characterized BDV isolates form the family Bornaviridae with-
in the order Mononegavirales. The BDV 8.9 kb RNA genome
comprises six open reading frames (ORFs): ORF I codes for
the nucleoprotein p40 (NP), ORF II for the phosphoprotein
p24 (P), ORF III for the matrix protein p16 (M), ORF IV for
the glycoprotein p57, ORF V for p180/190, the phosphory-
lated polymerase (L) [2]. A further ORF overlaps with the P
gene and encodes the protein p10 (X) [3].
The BDV glycoprotein precursor (GP) molecule encoded by
ORF IV is a type I membrane protein, consisting of 503
amino acids with a molecular mass of 57 kDa in the degly-
cosylated form (p57) and 84 or 94 kDa in the N-glycosylated
form previously designated as gp84, gp94 or G (Fig. 1A) [4^
6]. Precursor GP is cleaved at a basic tetrapeptide motif, C-
terminally of arginine 249, by furin or by other subtilisin-like
endoproteases. Proteolytic processing of GP is essential for
fusion capacity of BDV and thus for BDV infectivity [7,8].
Cleavage of GP results in the previously detected C-terminal,
membrane-anchored subunit GP-C (gp43) and a not yet iden-
ti¢ed N-terminal subunit GP-N. GP-N seems to be responsi-
ble for receptor binding as recently shown by a pseudotype
approach of vesicular stomatitis virus (VSV) containing a
BDV GP/VSV-G chimeric glycoprotein [9].
In this report, we identi¢ed the subunit GP-N present in
BDV-infected cells and in the virus-enriched preparations by a
combined method including: (i) the enrichment of di¡erent
BDV glycoprotein forms by lectin precipitation, (ii) endogly-
cosidase treatment, and (iii) immunochemical detection using
an antiserum raised against peptides corresponding to amino
acids 81^107 of the N-terminal part of GP. Furthermore, the
N-glycans of GP, GP-N and GP-C were characterized by
endoglycosidases and lectins.
2. Materials and methods
2.1. Propagation of BDV-infected cells
MDCK and Vero cells (African green monkey kidney cells) persis-
tently infected with the BDV [10,11] and uninfected MDCK and Vero
cells as controls were grown in Dulbecco’s modi¢ed Eagle’s medium
(DMEM) supplemented with 10% fetal calf serum, 2 mM L-glutamine,
50 units/ml penicillin, and 50 Wg/ml streptomycin. The cells were kept
at 37‡C with 5% CO2.
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2.2. Peptide antisera
The monospeci¢c antiserum Rb-KGP-N was obtained by immuni-
zation of rabbits with a chemical synthesized GP-speci¢c polypeptide
comprising the amino acids 81^107 of BDV GP (M. Kraus, IMT,
Marburg, Germany). The monospeci¢c rabbit antiserum Rb-KGP-C,
previously designated as Rb-KGP2, was described previously [7].
2.3. Electrophoresis and immunoblot analysis
BDV-infected material was dissolved with an equal volume of 2U
electrophoresis sample bu¡er containing 100 mM Tris^HCl (pH 6.8),
4% sodium dodecyl sulfate (SDS), 10% 2-mercaptoethanol, 20% glyc-
erol and 0.05% bromophenol blue, heated at 96‡C for 5 min. Proteins
were separated on 12% polyacrylamide gels by SDS^polyacrylamide
gel electrophoresis (PAGE), and electrophoretically transferred onto
nitrocellulose membranes (Schleicher and Schuell). The membranes
were blocked at 4‡C overnight with a solution of 3% bovine serum
albumin (BSA) in phosphate-bu¡ered saline with 0.1% Tween 20
(PBS-T). The blots were incubated for 1 h with peptide antisera,
Rb-KGP-C 1:400 diluted and Rb-KGP-N 1:300 diluted in PBS-T,
followed by an incubation of a 1:2000 diluted anti-rabbit immuno-
globulin G from swine complexed with horseradish peroxidase
(Dako). BDV-speci¢c glycoprotein bands were visualized using the
SuperSignal chemoluminescence substrate as described by the supplier
(Pierce).
2.4. Glycoprotein binding to lectin agarose
Detached cells from one 75 cm2 £ask were collected by centrifuga-
tion, washed once with PBS and dissolved in 600 Wl GDK1 bu¡er
consisting of 50 mM Tris^HCl (pH 6.8), 150 mM NaCl, 1 mM CaCl2,
1 mM MnCl2 and 2% SDS. Solubilized cells were treated for 1 min
with ultrasonic (Branson Soni¢er, 40 W) and 100 Wl aliquots were
1:10 diluted in GDK1 bu¡er.
The glycoproteins were precipitated by addition of 50 Wl concana-
valin A (ConA) agarose conjugate (Calbiochem-Novabiochem), Ga-
lanthus nivalis agglutinin (GNA) agarose conjugate or wheat germ
agglutinin (WGA) agarose conjugate (Alexis) to the diluted cell lysates
at 4‡C for 16 h. The glycoproteins bound to the lectin agarose beads
were washed three times with GDK1 bu¡er.
2.5. Deglycosylation by endoglycosidases
2.5.1. Deglycosylation before SDS^PAGE. Glycoproteins of cell
lysates precipitated by lectin agarose were denatured in 16 Wl electro-
phoresis sample bu¡er by heating for 10 min at 96‡C, cooled on ice
and centrifuged 10 min at 13 000 rpm (Biofuge, Heraeus). The super-
natants were 10-fold diluted in an appropriate reaction bu¡er for
deglycosylation enzymes, 50 mM sodium citrate (pH 5.5) or 50 mM
sodium phosphate (pH 7.5) in 1% NP-40, and incubated for 2 h at
37‡C with endoglycosidase H (Endo H) or peptide-N-glycosidase F
(PNGase F) (New England Biolabs), respectively. Deglycosylated pro-
tein samples were subjected to SDS^PAGE and immunoblot analysis.
2.5.2. Deglycosylation after SDS^PAGE. Proteins of lysed cells or
enriched lectin precipitations were separated by SDS^PAGE, trans-
ferred onto nitrocellulose membranes, equilibrated with 50 mM so-
dium acetate bu¡er (pH 5.5) for 20 min, and then incubated with 0.05
U/ml Endo H, diluted in sodium acetate bu¡er (pH 5.5) for 16 h at
37‡C [12]. Then, the nitrocellulose membranes were washed with 50
mM sodium acetate bu¡er (pH 5.5) followed by a PBS washing and
then blocked at 4‡C for at least 16 h with a solution of 3% BSA in
PBS-T and subjected to immunoblot analysis.
3. Results and discussion
3.1. Identi¢cation of the subunit GP-N
BDV GP is proteolytically processed similar to other viral
envelope glycoproteins [4,7,9]. However, only the membrane-
anchored subunit GP-C was described in BDV-infected cells
and puri¢ed BDV virions. The other cleavage product(s), i.e.
one or several N-terminal subunit(s) remained unidenti¢ed. In
order to characterize N-terminal cleavage product(s), we used
the monospeci¢c antiserum Rb-KGP-N. When proteins of
lysed BDV-infected cells were separated by SDS^PAGE and
electrophoretically blotted on nitrocellulose membrane, Rb-
KGP-N speci¢cally reacts only with one band with the ap-
proximate molecular mass of 94 kDa indicating uncleaved
GP (Fig. 1B, lower blot, lanes 1 and 2). No other BDV-spe-
ci¢c band could be detected from BDV-infected and unin-
fected control cells. When a parallel blot was incubated with
the Rb-KGP-C serum, uncleaved GP, and in addition the sub-
unit GP-C were detected (Fig. 1B, upper blot, lanes 1 and 2).
The lack of any detectable N-terminal cleavage fragment by
the Rb-KGP-N raised the question whether GP-N is instable
and rapidly degraded or whether the putative subunit GP-N
remains undetectable because the linear antigenic epitope for
the Rb-KGP-N antiserum was shielded by N-glycans after
cleavage of the precursor GP. In order to analyze the latter
possibility, the BDV glycoprotein was ¢rst enriched by pre-
cipitation with various lectin agarose beads. Secondly, after
separation of the glycoproteins by SDS^PAGE and electro-
blotting onto nitrocellulose membranes, the blots were exten-
sively treated with Endo H to remove mannose-rich carbohy-
drates and, thus, accomplish access to the linear antigenic
epitope for the Rb-KGP-N serum. After these procedures,
the BDV glycoprotein was detected by immunochemistry us-
ing Rb-KGP-N serum. Several lectins, among them ConA,
GNA and WGA, precipitated the BDV glycoprotein from
lysates of BDV-infected cells. WGA recognizes N-acetyl-L-
(1,4)-D-glucosamine, ConA K-D-glucose and K-D-mannose,
and GNA high mannose containing N-glycans. The subunit
GP-N and the precursor GP of the BDV-infected cells immu-
nochemically reacted with Rb-KGP-N serum on the blots after
deglycosylation on blot indicating that the linear epitope of
the BDV GP-N is indeed covered by N-glycans (Fig. 1B, lanes
4, 6, 8, lower blot). GP-C and GP were detected by Rb-KGP-
C serum BDV-infected under the same conditions (Fig. 1B,
lanes 4, 6, 8, upper blot). GP appears as a band with an
apparent molecular mass in the range of 84^94 kDa on
both blots. GP-N appears as a broad band with a molecular
mass between 45 and 55 kDa (Fig. 1B, lanes 4, 6, 8, upper
blot) and GP-C as a 43 kDa band (Fig. 1B, lanes 4, 6, 8, lower
blot). Furthermore, GP-N was detected in virus-enriched
preparations (data not shown). The experimentally deter-
mined molecular mass of GP-N is in accordance with the
calculated molecular mass of about 51 kDa composed of
the non-glycosylated GP-N with a molecular mass of 27
kDa and an additional mass of 27 kDa for potential N-gly-
cans. GP-N contains nine predicted N-glycans, each with an
average molecular mass of 3 kDa.
3.2. Speci¢cation of N-glycans in BDV-infected cells
To specify the N-glycans of GP, GP-N and GP-C, the gly-
coprotein of BDV-infected cells was ¢rst enriched from lysed
cells by precipitation either with ConA agarose beads (Fig.
2A) or with GNA agarose beads (Fig. 2B). Subsequently,
the BDV glycoprotein was treated either with Endo H or
PNGase F as indicated and the deglycosylated proteins were
separated by SDS^PAGE. Using this approach, the removal
of mannose-rich (Endo H sensitive) and complex-type
(PNGase F sensitive) N-glycans from BDV GP, GP-N and
GP-C was achieved. Treatment of GP with either Endo H
or PNGase F results in the totally deglycosylated form with
the expected molecular mass of 57 kDa (Fig. 2A, lanes 4 and
6; Fig. 2B, lanes 4 and 6). These results are in agreement with
the concept that all or nearly all N-glycosylation sites of GP
are occupied with mannose-rich glycans. The digestion of GP-
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C with PNGase F resulted in the non-glycosylated form GP-
C** with a molecular mass of about 30 kDa (Fig. 2A, lane 6).
Interestingly, Endo H only partially removed the N-glycans
from GP-C and led to a semi-deglycosylated GP-C* with a
molecular mass of about 35 kDa (Fig. 2A, lane 4). Two of
four potential N-glycosylation sites of GP-C may be occupied
Fig. 1. A: Schematic overview of the BDV glycoprotein. The GP
(gp84, gp94, G) and the subunits GP-C (gp43) and GP-N (gp51)
are shown. Signal peptide (black box), furin cleavage site (¢lled tri-
angle), transmembrane domain (strips), antisera recognition sites for
Rb-KGP-N and Rb-KGP-C (black beams) and potential attachment
sites for N-glycans (tree-like symbols) are indicated. Numbers show
the amino acid positions. B: Identi¢cation of BDV GP-N. Immuno-
blot analysis of material of BDV-infected Vero cells (lanes 1 and 2)
and MDCK cells (lanes 3^8) and respective control cells using the
N-terminal speci¢c (Rb-KGP-N) and C-terminal speci¢c (Rb-KGP-
C) anti-peptide sera. Glycoproteins of dissolved cells were precipi-
tated by ConA, GNA, or WGA. Uncleaved BDV GP, and subunits
GP-N and GP-C are indicated. Prior to immunodetection the glyco-
proteins were enzymatically deglycosylated by Endo H.
Fig. 2. Various deglycosylated forms of the BDV glycoproteins. A:
Immunoblot analyses were performed with material of BDV-infected
MDCK cells or of non-infected MDCK cells as controls which was
¢rst precipitated by ConA agarose beads and secondly treated with
either Endo H or PNGase F. BDV GP, uncleaved and non-glycosy-
lated BDV GP (p57), the membrane-anchored glycoprotein subunit
with mature N-glycans GP-C, the C-terminal subunit with Endo H
resistant N-glycans GP-C*, and the totally deglycosylated subunit
GP-C** are shown. B: Immunoblot analyses of GNA precipitated
and endoglycosidase treated material of BDV-infected MDCK cells
and control cells were done according to A. The N-terminal subunit
with Endo H resistant N-glycans GP-N*, and the totally deglycosy-
lated GP-N** are shown.
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by N-glycans of the complex type and two other sites may be
occupied by mannose-rich glycans.
Deglycosylation of GP-N by PNGase F and immunoblot
analysis with the N-terminal peptide antiserum thereafter re-
sulted in the loss of all N-glycans and the remaining polypep-
tide GP-N** of 27 kDa (Fig. 2B, lane 6). When GP-N was
treated with Endo H, only several partially deglycosylated
bands were obtained on the blots (Fig. 2B, lane 4). The results
for the GP-N were independent whether lectins with speci¢c-
ities for mannose-rich or complex-type N-glycans were used.
The data indicate that the precursor GP contains immature
N-glycans, which are all Endo H sensitive, the GP-C possesses
two complex and two mannose-rich N-glycans, whereas GP-N
contains nine N-glycans of both glycotypes.
The translated sequence of BDV ORF IV represents a pro-
tein of 57 kDa [13], which was later described as an N-glyco-
sylated envelope protein of BDV (gp83, gp94, GP) [4,6,7].
Analogous to other viral glycoproteins of the Mononegavirales
order, the glycoprotein cleavage by soluble furin was shown,
which is important for virus propagation [7]. Until now, only
the membrane-anchored C-terminal subunit and not the distal
N-terminal subunit of the BDV glycoprotein was described
for BDV-infected material. The ¢rst experimental indication
for an N-terminal subunit of the BDV glycoprotein was ob-
tained from in vitro transcription and translation of unglyco-
sylated 57 kDa polypeptide of the BDV ORF IV [7]. Furin
cleaved the unglycosylated precursor BDV GP in two frag-
ments of distinct sizes, 29 and 27 kDa, respectively. This ¢nd-
ing argued for the usage of the furin cleavage site at amino
acid position 249, although two other furin cleavage motifs
are present within BDV GP. The non-glycosylated in vitro
generated fragments represent the corresponding subunits of
GP-C and GP-N, obtained from BDV-infected cells after de-
glycosylation as shown in this report. The di⁄culties for GP-
N identi¢cation were based on the lack of suitable antibodies
for detection of the N-terminal part of the BDV glycoprotein
and an appropriate detection method. The immunodetection
is complicated due to the low antigenicity of the BDV GP-N
and the high content of N-glycans which shield antigenic sites.
About 50% of the total molecular mass of GP-N is attributed
to its N-glycans. For other highly glycosylated molecules it
might be of interest that glycan removal by Endo H prior
to SDS^PAGE did not result in detection after immunoblot
analyses. But the detection was successful after removal of the
glycans on blot. Obviously, the same glycan structures appear
to be only accessible for deglycosylation after denaturation of
an immobilization on nitrocellulose. High glycan content
might protects the BDV glycoprotein surface against the
host immune attack and supports the establishment of a per-
sistent infection.
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